A randomized trial of in-hospital initiation of an SGLT2 inhibitor in patients with heart failure missed its endpoint, but a ...

Over 3 years, SGLT2 inhibitors were safely associated with a nearly one third reduction in the risk for serious liver events.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

The link between diabetes and dementia is becoming increasingly clear. New research shows how blood sugar problems affect ...

Diabetes can also weaken the brain's protective barrier, letting harmful substances in. This leads to inflammation. Reduced ...

Germany: Researchers have found in a new study of 28,441 patients with type 2 diabetes that SGLT2 inhibitors were associated ...

Well, for cardiologist Dr Dmitry Yaranov (who goes by Heart Transplant Doc on social media), there are five rules he said he ...

As the prevalence of both chronic kidney disease (CKD) and heart failure (HF) increases, therapies targeting shared pathways ...

The link between diabetes and dementia is becoming increasingly clear. New research shows how blood sugar problems affect ...

In-hospital initiation of dapagliflozin did not significantly reduce the short-term risk of cardiovascular death or worsening ...

The leaders of China and Russia discussed medical advances and whether a human might reach the age of 150. Two experts in the ...